Clinical trials

  • Humanised IgG1 monoclonal antibody against PD-L1 conjugated to monomethyl auristatin E via a valine-citrulline linker for Non-small cell lung cancer
  • ICOTROKINRA for Ulcerative colitis | Moderately to severely active ulcerative colitis
  • TYRA-300-B01 for Non-muscle invasive bladder cancer
  • Tocilizumab for Acute ischemic stroke|Ischaemic stroke
  • DUPILUMAB for Chronic obstructive pulmonary disease
  • FOLINIC ACID for Oesophageal adenocarcinoma|Gastroesophageal junction adenocarcinoma
  • 4-((2,4-DIFLUOROPHENYL)METHYL)2,4,6,7,8,9-HEXAHYDRO-7(PHENYLMETHYL)IMIDAZO(1,2-A)PYRIDO(3,4-E)PYRIMIDIN-5(1H)-ONE for Diffuse midline glioma | Primary malignant central nervous system tumours
  • RUZASVIR, BEMNIFOSBUVIR for Chronic hepatitis C
  • BI 3819026 for Unresectable advanced or metastatic solid cancer
  • BRENTUXIMAB VEDOTIN for Cutaneous T-cell lymphoma | Mycosis fungoides
  • sufentanil citrate for Severe acute trauma-related pain
  • BGB-16673 for Chronic lymphocytic leukemia | Small lymphocytic lymphoma